Fetal Stem Cells: Betwixt and Between

Pascale V. Guillot; Keelin O'Donoghue; Hitoshi Kurata; Nicholas M. Fisk

doi:10.1055/s-2006-952149

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2006; 24(5): 340-347
DOI: 10.1055/s-2006-952149

Fetal Stem Cells: Betwixt and Between

Pascale V. Guillot¹ , Keelin O'Donoghue¹ ^, ² , Hitoshi Kurata¹ , Nicholas M. Fisk¹ ^, ²

¹Experimental Fetal Medicine Group, Institute of Reproductive and Developmental Biology, Imperial College, London, United Kingdom
²Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Hammersmith Hospitals Trust, London, United Kingdom

Abstract

ABSTRACT

Fetal stem cells can be isolated not only from fetal blood and hemopoietic organs in early pregnancy, but from a variety of somatic organs as well as amniotic fluid and placenta throughout gestation. Fetal blood is a rich source of hemopoietic stem cells, which proliferate more rapidly than those in cord blood or adult bone marrow. First-trimester fetal blood, liver, and bone marrow also contain a population of mesenchymal stem cells, which appear to be more primitive with greater multipotentiality than their adult counterparts. Fetal stem cells may thus represent an intermediate cell type in the current debate focusing on dichotomized adult versus embryonic stem cells, and thus prove advantageous as a source for downstream cell therapy applications. They have also been implicated in fetomaternal trafficking in pregnancy, and in long-term microchimerism in postreproductive women.

KEYWORDS

Fetal tissue - fetal and cord blood - mesenchymal stem cell - hemopoietic stem cell - fetal therapy - fetomaternal microchimerism

Full Text

References

REFERENCES

1 Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood. 2004; 103(8) 2892-2899
2 Sanchez-Ramos J. Stem cells from cord blood. Semin Reprod Med. 2006; 24 358-369
3 Campagnoli C, Fisk N, Overton T, Bennett P, Watts T, Roberts I. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood. 2000; 95(6) 1967-1972
4 Campagnoli C, Roberts I A, Kumar S, Bennett P R, Bellantuono I, Fisk N M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001; 98(8) 2396-2402
5 Orlandi F, Damiani G, Jakil C, Lauricella S, Bertolino O, Maggio A. The risks of early cordocentesis (12-21 weeks): analysis of 500 procedures. Prenat Diagn. 1990; 10(7) 425-428
6 Surbek D V, Tercanli S, Holzgreve W. Transabdominal first trimester embryofetoscopy as a potential approach to early in utero stem cell transplantation and gene therapy. Ultrasound Obstet Gynecol. 2000; 15(4) 302-307
7 Surbek D V, Young A, Danzer E, Schoeberlein A, Dudler L, Holzgreve W. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy. Am J Obstet Gynecol. 2002; 187(4) 960-963
8 Huss R. Isolation of primary and immortalized CD34-hematopoietic and mesenchymal stem cells from various sources. Stem Cells. 2000; 18(1) 1-9
9 Taylor P A, McElmurry R T, Lees C J, Harrison D E, Blazar B R. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood. 2002; 99(5) 1870-1872
10 Clapp D W, Freie B, Lee W H, Zhang Y Y. Molecular evidence that in situ-transduced fetal liver hematopoietic stem/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood. 1995; 86(6) 2113-2122
11 O'Donoghue K, Fisk N M. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18(6) 853-875
12 Tocci A, Forte L. Mesenchymal stem cell: use and perspectives. Hematol J. 2003; 4(2) 92-96
13 Lim F T, Kanhai H H, Falkenburg J H. Characterization of the human CD34 + hematopoietic progenitor cell compartment during the second trimester of pregnancy. Haematologica. 2005; 90(2) 173-179
14 De la Fuente J, O'Donoghue K, Kumar S, Chan J, Fisk N M, Roberts I A. Ontogeny-related changes in integrin expression and cytokine production by fetal mesenchymal stem cells (MSC). Blood. 2002; 100(11) 526a
15 Lee J, Elkahloun A G, Messina S A et al.. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res. 2003; 63(24) 8877-8889
16 Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001; 86(10) 1099-1100
17 Erices A, Conget P, Minguell J J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1) 235-242
18 Yu M, Xiao Z, Shen L, Li L. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol. 2004; 124(5) 666-675
19 Rollini P, Kaiser S, Faes-van't Hull E, Kapp U, Leyvraz S. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood. 2004; 103(3) 1166-1170
20 Nicolini U, Poblete A. Single intrauterine death in monochorionic twin pregnancies. Ultrasound Obstet Gynecol. 1999; 14 297-301
21 Zanjani E D, Ascensao J L, Tavassoli M. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood. 1993; 81(2) 399-404
22 Holyoake T L, Nicolini F E, Eaves C J. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999; 27(9) 1418-1427
23 Nava S, Westgren M, Jaksch M et al.. Characterization of cells in the developing human liver. Differentiation. 2005; 73(5) 249-260
24 Gotherstrom C, West A, Liden J, Uzunel M, Lahesmaa R, Le Blanc K. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica. 2005; 90(8) 1017-1026
25 in ‘t Anker P, Noort W A, Scherjon S A et al.. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003; 88(8) 845-852
26 Goossens E, Tournaye H. Testicular stem cells. Semin Reprod Med. 2006; 24 370-378
27 Le Blanc K, Gotherstrom C, Ringden O et al.. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005; 79(11) 1607-1614
28 Zanjani E D, Pallavicini M G, Ascensao J L et al.. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest. 1992; 89(4) 1178-1188
29 in ‘t Anker P S, Noort W A, Kruisselbrink A B et al.. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34( + ) cells in NOD/SCID mice. Exp Hematol. 2003; 31(10) 881-889
30 Hu Y, Liao L, Wang Q et al.. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 2003; 141(5) 342-349
31 Huang H, Tang X. Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. Lab Invest. 2003; 83(4) 539-547
32 Yao Z X, Qin M L, Liu J J, Chen X S, Zhou D S. In vitro cultivation of human fetal pancreatic ductal stem cells and their differentiation into insulin-producing cells. World J Gastroenterol. 2004; 10(10) 1452-1456
33 Al-Awqati Q, Oliver J A. Stem cells in the kidney. Kidney Int. 2002; 61(2) 387-395
34 Almeida-Porada G, El Shabrawy D, Porada C, Zanjani E D. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol. 2002; 30(12) 1454-1462
35 Almeida-Porada G, Porada C, Esmail D. Differentiation potential of human metanephric stem cells: from mesenchyme to blood. Blood. 2000; 96 494a
36 Almeida-Porada G, Crapnell K, Porada C et al.. In vivo haematopoietic potential of human neural stem cells. Br J Haematol. 2005; 130 276-283
37 Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18(6) 877-891
38 Kaviani A, Guleserian K, Perry T E, Jennings R W, Ziegler M M, Fauza D O. Fetal tissue engineering from amniotic fluid. J Am Coll Surg. 2003; 196(4) 592-597
39 Tsai M S, Lee J L, Chang Y J, Hwang S M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004; 19(6) 1450-1456
40 in ‘t Anker P S, Scherjon S A, Kleijburg-van der Keur C et al.. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102(4) 1548-1549
41 Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation. 2005; 79(5) 528-535
42 Haigh T, Chen C, Jones C J, Aplin J D. Studies of mesenchymal cells from 1st trimester human placenta: expression of cytokeratin outside the trophoblast lineage. Placenta. 1999; 20(8) 615-625
43 Zhang Y, Li C, Jiang X, Li H, Tang P, Mao N. Comparison of mesenchymal stem cells from human placenta and bone marrow. Chin Med J (Engl). 2004; 117(6) 882-887
44 Li C D, Zhang W Y, Li H L et al.. Isolation and identification of a multilineage potential mesenchymal cell from human placenta. Placenta 2005 [Epub ahead of print]
45 Young H E, Steele T A, Bray R A et al.. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 2001; 264(1) 51-62
46 Valerio D, Altieri V, Antonucci F R, Aiello R. Characterization of fetal haematopoietic progenitors circulating in maternal blood of seven aneuploid pregnancies. Prenat Diagn. 1997; 17(12) 1159-1169
47 Campagnoli C, Roberts I A, Kumar S et al.. Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. Prenat Diagn. 2002; 22(6) 463-469
48 O'Donoghue K, Choolani M, Chan J et al.. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod. 2003; 9(8) 497-502
49 Bianchi D W, Zickwolf G K, Weil G J, Sylvester S, DeMaria M A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996; 93(2) 705-708
50 O'Donoghue K, Chan J, de la Fuente J et al.. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004; 364(9429) 179-182
51 Khosrotehrani K, Bianchi D W. Fetal cell microchimerism: helpful or harmful to the parous woman?. Curr Opin Obstet Gynecol. 2003; 15(2) 195-199
52 Srivatsa B, Srivatsa S, Johnson K L, Samura O, Lee S L, Bianchi D W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet. 2001; 358(9298) 2034-2038
53 Khosrotehrani K, Johnson K L, Cha D H, Salomon R N, Bianchi D W. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004; 292(1) 75-80
54 Khosrotehrani K, Johnson K L, Lau J, Dupuy A, Cha D H, Bianchi D W. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum. 2003; 48(11) 3237-3241
55 Khosrotehrani K, Bianchi D. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci. 2005; 118 1559-1563
56 MacKenzie T S, Campagnoli C, Almeida-Porada G, Fisk N M, Flake A W. Circulating human fetal stromal cells engraft and differentiate in multiple tissues following transplantation into pre-immune fetal lambs. Blood. 2001; 98 328a
57 de la Fuente J, Fisk N, O'Donoghue K, Chan J, Kumar S, Roberts I. α2β1 and α4β1 integrins mediate the homing of mesenchymal stem/progenitor cells during fetal life. Haematol J. 2003; 4(suppl 2) 13
58 Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol. 2004; 190(1) 239-245
59 Chan J, O'Donoghue K, de la Fuente J et al.. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells. 2005; 23(1) 93-102
60 Schoeberlein A, Holzgreve W, Dudler L, Hahn S, Surbek D V. Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses. Am J Obstet Gynecol. 2005; 192(4) 1044-1052
61 Mackenzie T C, Shaaban A F, Radu A, Flake A W. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg. 2002; 37(7) 1058-1064
62 Fukada S, Miyagoe-Suzuki Y, Tsukihara H et al.. Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J Cell Sci. 2002; 115(pt 6) 1285-1293
63 in ‘t Anker P S, Scherjon S A, Kleijburg-van der Keur C et al.. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004; 22(7) 1338-1345

Pascale V GuillotPh.D.

Experimental Fetal Medicine Group, Institute of Reproductive and Developmental Biology, Division of Surgery, Oncology, Reproductive Biology & Anaesthesia, Imperial College London

Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom

Email: Pascale.Guillot@imperial.ac.uk